ProfileGDS5822 / ILMN_2868013
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 72% 77% 73% 68% 79% 70% 80% 75% 74% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 161.572
GSM1276600PDAC Late Ablation Control 2105.677
GSM1276601PDAC Late Ablation Control 399.873
GSM1276602PDAC Late Ablation 139.868
GSM1276603PDAC Late Ablation 2134.579
GSM1276604PDAC Late Ablation 356.570
GSM1303940PDAC Late Ablation_anti-CTLA4 1137.380
GSM1303941PDAC Late Ablation_anti-CTLA4 2109.275
GSM1303942PDAC Late Ablation_anti-CTLA4 3100.774